Charles W. Newton - 17 Mar 2025 Form 4 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Signature
/s/ Matthew Lang, as Attorney-in-Fact
Issuer symbol
LYEL
Transactions as of
17 Mar 2025
Transactions value $
$111,620
Form type
4
Filing time
18 Mar 2025, 19:01:35
Previous filing
26 Feb 2025
Next filing
29 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LYEL Common Stock Purchase $112K +200K $0.56 200K 17 Mar 2025 Co-grantor and Co-trustee F1, F2
holding LYEL Common Stock 173K 17 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported above reflects the weighted average price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $0.54 to $0.56, inclusive. Upon request from the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this range
F2 Shares held by The Charles & Lisa Newton Living Trust. The Reporting Person is co-trustee and co-grantor of The Charles & Lisa Newton Living Trust.